Mateusz Kaczmarski
Biographic Data
| ID | 7872113 |
|---|---|
| NAME | Mateusz Kaczmarski |
| GIVEN NAMES | Mateusz |
| FAMILY NAME | Kaczmarski |
| SIGNATURE | KACZMARSKI M |
| AFFILIATIONS | Jan Grodek State Vocational Academy in Sanok |
| ORCID | 0000-0003-4498-7110 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Influence of Selected Indicators of Healthcare System Functioning Evaluation on the Health Result
Life expectancy is positively correlated with access to general health insurance and public expenditure on healthcare. There is a need for all countries to provide their citizens with broad access to healthcare services
Civil Lawsuits as an Indicator of Adverse Outcomes in Healthcare
The financial burden of adverse healthcare outcomes in Poland still remains unknown. The objective of the study was to estimate the cost of adverse healthcare outcomes in the Polish healthcare system. Cost calculation was performed on the basis of civil cases completed in Polish courts against doctors and healthcare entities. The research material consisted of 183 civil cases completed by a final judgment in 2011-2013. The case study was conducte…
The Sense of Coherence and Health Behavior of Men with Alcohol Addiction
Individuals addicted to alcohol are characterized by a low SOC and a low level of pro-health behaviors. Strengthening the internal level of the SOC can constitute an element of addiction therapy when introducing health education to prepare the patient for independent life in sobriety
Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US Orphan Drugs Act Modifications and Discussed Price-Regulation Mechanisms Adjustments in US and European Union
The 2019 worldwide sales of Orphan Drugs were estimated at $136 billion USD, which constituted 16% of the global pharmaceutical prescription market and is expected to grow by 12% in the next 5 years. A better understanding of Orphan Drug pricing may contribute to on-going discussions on Orphan Drug Act (ODA) corrections in US or modifications of price setting mechanisms in EU. The objective of the study was comparison and analysis of the prices o…
No prominent works on this page.
Influence of Selected Indicators of Healthcare System Functioning Evaluation on the Health Result
Life expectancy is positively correlated with access to general health insurance and public expenditure on healthcare. There is a need for all countries to provide their citizens with broad access to healthcare services
Civil Lawsuits as an Indicator of Adverse Outcomes in Healthcare
The financial burden of adverse healthcare outcomes in Poland still remains unknown. The objective of the study was to estimate the cost of adverse healthcare outcomes in the Polish healthcare system. Cost calculation was performed on the basis of civil cases completed in Polish courts against doctors and healthcare entities. The research material consisted of 183 civil cases completed by a final judgment in 2011-2013. The case study was conducte…
The Sense of Coherence and Health Behavior of Men with Alcohol Addiction
Individuals addicted to alcohol are characterized by a low SOC and a low level of pro-health behaviors. Strengthening the internal level of the SOC can constitute an element of addiction therapy when introducing health education to prepare the patient for independent life in sobriety
Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US Orphan Drugs Act Modifications and Discussed Price-Regulation Mechanisms Adjustments in US and European Union
The 2019 worldwide sales of Orphan Drugs were estimated at $136 billion USD, which constituted 16% of the global pharmaceutical prescription market and is expected to grow by 12% in the next 5 years. A better understanding of Orphan Drug pricing may contribute to on-going discussions on Orphan Drug Act (ODA) corrections in US or modifications of price setting mechanisms in EU. The objective of the study was comparison and analysis of the prices o…
Medicine (4 works) · Business (3 works) · Psychology (3 works) · Economic growth (2 works) · Economics (2 works) · Environmental health (2 works) · Gerontology (2 works) · Health care (2 works) · Health Systems, Economic Evaluations, Quality of Life (2 works) · Healthcare Policy and Management (2 works)